(Q34980299)

5 August 2017

Application of COLD-PCR for improved detection of KRAS mutations in clinical samples (English)

1 reference

5 August 2017

Zhuang Zuo

1

1 reference

5 August 2017

Su S Chen

2

1 reference

5 August 2017

Pranil K Chandra

3

1 reference

5 August 2017

John M Galbincea

4

1 reference

5 August 2017

Matthew Soape

5

1 reference

5 August 2017

Steven Doan

6

1 reference

5 August 2017

Bedia A Barkoh

7

1 reference

5 August 2017

Hartmut Koeppen

8

1 reference

5 August 2017

L Jeffrey Medeiros

9

1 reference

5 August 2017

Rajyalakshmi Luthra

10

1 reference

5 August 2017

8 May 2009

1 reference

5 August 2017

1 reference

5 August 2017

22

1 reference

5 August 2017

1023-1031

1 reference

5 August 2017

8

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2009.59

5 August 2017

0 references

cites work

Ras oncogenes: split personalities

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

KRAS mutation is an important predictor of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Clinical relevance of KRAS mutation detection in metastatic colorectal cancer treated by Cetuximab plus chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Clinical interest of KRAS mutation detection in blood for anti-EGFR therapies in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Sensitive sequencing method for KRAS mutation detection by Pyrosequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

FLAG assay as a novel method for real-time signal generation during PCR: application to detection and genotyping of KRAS codon 12 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

s-RT-MELT for rapid mutation scanning using enzymatic selection and real time DNA-melting: new potential for multiplex genetic analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Replacing PCR with COLD-PCR enriches variant DNA sequences and redefines the sensitivity of genetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Thermal denaturation of double-stranded nucleic acids: prediction of temperatures critical for gradient gel electrophoresis and polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

DNA Basepair Step Deformability Inferred from Molecular Dynamics Simulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

Impact of point-mutations on the hybridization affinity of surface-bound DNA/DNA and RNA/DNA oligonucleotide-duplexes: comparison of single base mismatches and base bulges

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

7 January 2021

Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal cancer patients treated with cetuximab

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

7 January 2021

Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

7 January 2021

Enrichment of mutant KRAS alleles in pancreatic juice by subtractive iterative polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2009.59

7 January 2021

10.1038/MODPATHOL.2009.59

Identifiers

DOI

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference